Skip to main content

Case Comprehensive Cancer Center

AACI national meeting, presentation by Doug Lowy, Acting Director of NCI
This past week attended the national meeting of the Association of American Cancer Institutes (AACI) in Chicago. It was an excellent meeting of cancer center directors and administrators that included discussion of implementation of genomic tumor boards, use of molecular testing in clinical practic...
hooper1
Hero Type
Image
5 questions with… cancer disparities researcher Monica Webb Hooper
When Monica Webb Hooper saw a Facebook post about an opening to establish and direct the Office of Cancer Disparities Research at Case Western Reserve University, she knew it had her name written all over it. She didn’t know much about Cleveland, but when she came here from the University of Miami ...
Researchers Restore Drug Sensitivity in Breast Cancer Tumors
Findings confirmed in patient biopsies and laboratory models A team of Case Comprehensive Cancer Center researchers has uncovered one way certain tumors resist vital medication. In the study published in Oncotarget (Merry CR. Oncotarget. 2016 Jul 16), the researchers studied tumor biopsies collect...
VeloSano 3
7 am Saturday morning saw the 100 and 200+ mile Velosano bikers head off with the cheers of friends and leaders - I saw Brian Bolwell safely behind the roadside barrier smiling, arms raised. The day was perfect for riders - cool, with a short thunderstorm on the way in and a relaxing scenic route t...
stan-gerson
Hero Type
Image
Case Comprehensive Cancer Center director Stanton Gerson writes about Cancer Moonshot
Stanton L. Gerson, director of the Case Comprehensive Cancer Center, wrote a guest column for The Plain Dealer about Vice President Joe Biden’s Cancer Moonshot. His column, titled “Cleveland matters for Vice President Biden's Cancer Moonshot,” detailed how teams in Cleveland have worked with the vi...
Anant-Madabhushi
Hero Type
Image
Changes in benign tissue next to prostate tumors may predict biochemical recurrence of cancer, scientists find
Changes in benign tissues next to prostate tumors may provide an early warning for patients at higher risk for biochemical recurrence after a radical prostatectomy, a study by researchers at Case Western Reserve University and Johns Hopkins Medical Institutions shows. Biochemical recurrence, which ...
Cancer Moonshot Breakfast Panel
Message from the Associate Director: Brian Bolwell, MD Thomas Donohue, President and CEO, US Chamber of Commerce, hosted a Cancer Moonshot Breakfast Panel in downtown Cleveland last Wednesday. I participated in the panel, along with Toby Cosgrove, MD, President and CEO of Cleveland Clinic, Louis D...
music%20manuscript.jpg
Hero Type
Image
NCCN Publication: Value Access Cost of Cancer Care Delivery
Many of us are concerned with improving the cost of care in the setting of major cancer care centers, such as those at Cleveland Clinic and Seidman Cancer Center and their network sites. A publication from members of the National Comprehensive Cancer Network (NCCN) on the "Value Access Cost of Canc...
Nicole-Steinmetz
Hero Type
Image
Drug candidate shrinks tumor when delivered by plant virus nanoparticle
Phenanthriplatin outperformed cisplatin in mouse model of triple-negative breast cancer when encapsulated into nanocarrier In a pair of firsts, researchers at Case Western Reserve University and Massachusetts Institute of Technology have shown that the drug candidate phenanthriplatin can be more eff...
Webb Hooper Appointed Director of New Office of Cancer Disparities Research
Case Comprehensive Cancer Center welcomes Monica Webb Hooper, PhD as Director of the new Office of Cancer Disparities Research. She is also Professor of General Medical Sciences (Oncology), Family Medicine, Epidemiology & Biostatistics, and Psychological Sciences at Case Western Reserve University S...